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ABSTRACT
Objective: To determine the effect of contact with
a podiatrist on the occurrence of Lower Extremity
Amputation (LEA) in people with diabetes.
Design and data sources: We conducted a
systematic review of available literature on the effect of
contact with a podiatrist on the risk of LEA in people
with diabetes. Eligible studies, published in English,
were identified through searches of PubMed, CINAHL,
EMBASE and Cochrane databases. The key terms,
‘podiatry’, ‘amputation’ and ‘diabetes’, were searched
as Medical Subject Heading terms. Reference lists of
selected papers were hand-searched for additional
articles. No date restrictions were imposed.
Study selection: Published randomised and
analytical observational studies of the effect of contact
with a podiatrist on the risk of LEA in people with
diabetes were included. Cross-sectional studies, review
articles, chart reviews and case series were excluded.
Two reviewers independently assessed titles, abstracts
and full articles to identify eligible studies and extracted
data related to the study design, characteristics of
participants, interventions, outcomes, control for
confounding factors and risk estimates.
Analysis: Meta-analysis was performed separately for
randomised and non-randomised studies. Relative risks
(RRs) with 95% CIs were estimated with fixed and
random effects models as appropriate.
Results: Six studies met the inclusion criteria and five
provided data included in meta-analysis. The identified
studies were heterogenous in design and included
people with diabetes at both low and high risk of
amputation. Contact with a podiatrist did not
significantly affect the RR of LEA in a meta-analysis
of available data from randomised controlled trials
(RCTs); (1.41, 95% CI 0.20 to 9.78, 2 RCTs) or from
cohort studies; (0.73, 95% CI 0.39 to 1.33, 3 Cohort
studies with four substudies in one cohort).
Conclusions: There are very limited data available on
the effect of contact with a podiatrist on the risk of LEA
in people with diabetes.
INTRODUCTION
A worldwide diabetes epidemic is unfolding.1
Diabetes is associated with a signiﬁcantly
increased risk of Lower Extremity
Amputation (LEA). LEA rates vary between
populations with estimates ranging from 46
to 9600/105 people with diabetes.2 A
number of factors inﬂuence the occurrence
of an LEA in people with diabetes; including
ARTICLE SUMMARY
Article focus
▪ People with diabetes are at increased risk of
Lower Extremity Amputation (LEA). As the preva-
lence of diabetes escalates worldwide, it is
anticipated that there will be an increase in the
number of LEAs.
▪ It is assumed that contact with a podiatrist pre-
vents the occurrence of an LEA.
▪ This systematic review aims to determine from
available literature the documented effect of
contact with a podiatrist on the occurrence of an
LEA in people with diabetes.
Key messages
▪ Very limited data are available and the authors
conclude that there is insufficient evidence to
determine whether contact with a podiatrist has
an effect on the risk of LEA in people with
diabetes.
▪ Some existing studies suggest that contact with
a podiatrist has a positive effect on shorter-term
outcomes including patient knowledge of foot
care and ulcer recurrence.
▪ Further research on the long-term outcome of
LEA is warranted.
Strengths and limitations of this study
▪ This is the first systematic review which investi-
gates if contact with a podiatrist prevents the
occurrence of an LEA in people with diabetes.
▪ Failure to demonstrate an effect on this long-
term outcome is most likely due to limitations of
available studies.
▪ Limitations include that studies in this systematic
review looked at different sample populations
ranging from patients with low baseline risk to
patients with active disease. Also, included rando-
mised controlled trials were underpowered to detect
a significant difference for the outcome of LEA.
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hypertension, obesity and hyperglycaemia.3 4 In the
foot, previous ulceration, infection and ischaemia are
proven risk factors.5 Nearly 85% of amputations begin as
foot ulcers among persons with diabetes.6 Protective
factors include control of clinical parameters and
screening to identify those people at high risk and many
LEAs are preventable.7 8 The effects of clinical and
sociodemographic risk factors on the occurrence of an
LEA have been well documented in people with dia-
betes.9–12
In 2008, a task force report by the Foot Care Interest
Group of the American Diabetes Association, which
included podiatrists, stated that all people with diabetes
should be assigned to a foot risk category.13 These cat-
egories were designed to direct referral to and subse-
quent therapy by a speciality clinician or team but did
not refer speciﬁcally to the role of podiatry. Recent
guidelines from Scotland outline a diabetic-risk stratiﬁca-
tion and triage tool, highlighting which people need
podiatry referral. According to these guidelines, all
patients classiﬁed as moderate risk (ie, at least one risk
factor present), severe risk or with active disease require
podiatry review.14 Podiatry is practiced as a specialty in
many countries and in many English-speaking countries,
the older term of ‘chiropodist’ may still be used.
According to the National Health Service in the UK,
there is no difference between a chiropodist and a
podiatrist.15 It is assumed that podiatrists prevent LEAs
by treating existing disease and educating people with
diabetes on proper foot care. However, the effect of
patient contact with a podiatrist on the risk of LEA in
people with diabetes is unproven.
Two previous Cochrane reviews by Dorresteijn et al16 17
have looked ﬁrst at the effect of an integrated care approach
and second, the effect of patient education on the outcome
of LEA in people with diabetes. The ﬁrst of these reviews
found no high-quality evidence evaluating an integrated
care approach and insufﬁcient evidence of beneﬁt in pre-
venting diabetic foot ulceration.16 The second review,
updated in 2012, concluded that there is insufﬁcient robust
evidence that limited patient education alone is effective in
achieving clinically relevant reductions in ulcer and LEA
incidence.17 Individual patient contact with a podiatrist was
not examined as an intervention in either review. Thus, the
objective of the present systematic review of the published lit-
erature is to examine the effect of contact with a podiatrist
on risk of LEA in people with diabetes.
METHODS
The research question, inclusion and exclusion criteria
and proposed methods of analysis were speciﬁed in
advance and documented in a protocol (attached as a
supplementary ﬁle).
Search Strategy
PubMed, CINAHL, EMBASE (Excerpta Medica) and
Cochrane databases were searched to identify relevant
studies published up to and including 25 September
2011. The key terms, ‘podiatry’, ‘amputation’ and ‘dia-
betes’, were searched as Medical Subject Heading terms.
Randomised and observational studies, published in
English, which reported the effect of contact with a
podiatrist on risk of LEA in people with diabetes (type 1
or 2), were included. No date restrictions were imposed.
Cross-sectional studies, review articles, non-systematic
reviews, chart reviews and case series were excluded. A
manual search for references cited in relevant articles
was performed. All potentially eligible studies were inde-
pendently reviewed by two authors (CMB and PMK).
Data abstraction and quality assessment:
Using a standardised data collection form, two reviewers
(CMB and PMK) independently abstracted information
on the study design, year of study, characteristics of parti-
cipants, interventions and outcomes, control for poten-
tial confounding factors and risk estimates. A modiﬁed
version of a checklist developed by Downs and Black for
assessing the methodological quality of both randomised
and non-randomised studies of healthcare interventions
was used to critically appraise the studies in this review.18
Inconsistencies between reviewers were discussed and
resolved through consensus.
Statistical analysis
Review Manager Software V.5 (Revman 5.0; the
Cochrane Collaboration, Oxford, England) and STATA
V.12IC were used for statistical analysis. The relative risk
(RR) with 95% CI was recorded for included studies.
One study presented individual results for four various
stages of disease so this study was analysed as four substu-
dies. Meta-analysis was performed separately for rando-
mised and non-randomised studies, using either the
ﬁxed or random effects model as appropriate. Statistical
heterogeneity was assessed with Cochran’s Q statistic.
Cochran’s Q is computed by summing the squared
deviations of each study’s estimate from the overall
meta-analytic estimate, weighting each study’s contribu-
tion in the same manner as in the meta-analysis. p
Values were obtained by comparing the statistic with a
χ² distribution with k−1° of freedom (where k is the
number of studies).19 To assess publication bias, a
funnel plot of the overall estimate and its SE was
derived.
RESULTS
Four hundred and ninety-nine titles were retrieved from
searches of electronic databases. Duplicates (138) were
removed and 361 titles/abstracts were reviewed.
Eighteen papers were considered for review after initial
screening of titles and abstracts. Three further studies
were identiﬁed as potentially eligible from reference
checking. After reviewing the full text articles, six studies
met the inclusion criteria; two randomised controlled
trials (RCTs) and four cohort studies (ﬁgure 1).20
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Studies were excluded because of study design for
example, chart review/audit; intervention for example,
contact with a multidisciplinary team instead of contact
with a podiatrist; or in one case, the study was described
in another article already included in this systematic
review.
Table 1 describes the included studies according to
study design, participants, interventions and outcomes.
Quality of included studies was assessed and all studies
were deemed of suitable quality for inclusion (tables 2
and 3). Risk of foot disease at baseline was assessed
using the Diabetic foot risk stratiﬁcation and triage
system from the Scottish Intercollegiate Guidelines
Network (SIGN) guidelines (see online supplementary
appendix 1).14 Results of included studies are presented
in table 4.
Results from available studies were pooled together in
separate meta-analyses for RCTs and observational
studies. Five of these studies provided sufﬁcient data to
allow meta-analysis. For RCTs, the ﬁxed effects model
was applied (Q=0.328, p=0.567) and for cohort studies,
the random effects model is reported as there was evi-
dence of signiﬁcant heterogeneity between the cohort
studies (Q=32.698, p=0.000). Meta-analysis of the two
RCTs yielded an insigniﬁcant pooled RR of 1.41 (95%
CI 0.20 to 9.78) while meta-analysis of the cohort studies
also yielded an insigniﬁcant pooled RR of 0.73 (95% CI
0.39 to 1.33; ﬁgure 2).
Data required for inclusion in the meta-analysis was
unavailable for one eligible study. Lavery et al compared
people with diabetes on dialysis and people with dia-
betes with a history of a healed ulcer. During a
30-month evaluation period, only 30% of patients from
both groups combined were seen for preventative care
prior to ulceration. The amputation incidence density
was high in both groups (dialysis group 58.7 and ulcer
group 13.1/1000 person-years).21 However, it was not
possible to extract the LEA event rate in those who did
or did not have contact with a podiatrist.
Visual inspection of the funnel plot produced for the
included studies shows no strong evidence of publication
bias (ﬁgure 3).
DISCUSSION
In this systematic review, we conclude that there is insuf-
ﬁcient evidence to determine whether contact with a
podiatrist has an effect on LEA in people with diabetes.
Strengths and limitations of this review
This is the ﬁrst systematic review that the authors are
aware of that investigates if contact with a podiatrist pre-
vents the occurrence of an LEA in patients with dia-
betes. A thorough literature search examining multiple
databases was undertaken and six studies with two differ-
ent study designs were included. While individual study
design meta-analysis was performed in an effort to pool
the available data, we acknowledge that heterogeneity
exists between studies included in the meta-analysis in
terms of baseline diabetic foot risk and type of
intervention.
Included studies looked at different sample popula-
tions ranging from patients with low baseline risk to
patients with active disease. For example, Ronnemaa
et al22 recruited patients with diabetes from the national
drug imbursement register in Finland which is represen-
tative of the total population with diabetes. However,
Plank et al23 recruited patients with diabetes from a ter-
tiary referral centre which represents a population of
patients with diabetes that have developed complications
requiring referral to a tertiary centre. In ﬁve of the six
included studies, the population at risk were patients
with diabetes. However, Sowell et al24 examined a popu-
lation mix of patients with diabetes, peripheral vascular
disease (PVD) and gangrene. It was decided to include
this study due to the dearth of research in this area.
This difference in populations studied between the
Sowell paper and the other ﬁve studies needs to be high-
lighted as a limitation in this review.
The diabetic foot risk of the participants at baseline
(low-active) reﬂects the different treatment settings at
recruitment and highlights heterogeneity amongst the
studies (table 1). Cochran’s Q statistic was used to assess
heterogeneity. For RCTs, the ﬁxed effects model was
appropriate but this meta-analysis is limited as there are
only two included studies. For cohort studies, the
Q statistic of 32.698 (p=0.000) indicated that strong het-
erogeneity existed so the random effects model was
applied to account for both random variability and the
variability in effects among the studies. However, use of
the random effects model limits the conclusions that
can be drawn from the meta-analysis.25 ‘A priori’
Figure 1 PRISMA flow chart: selection of studies for
inclusion in review.
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Table 1 Characteristics of included studies
Study (author,
country, year)
Type of
study Participants Interventions
Source of data
used in study
Length of
follow-up
Baseline risk as per
diabetic foot risk
stratification14 Outcomes
Ronnemaa,
Finland,
199722 16
RCT 530 patients with diabetes
randomised
Intervention: 267
Control: 263
Intervention: 45 min individual
patient education
Podiatric care visits as
necessary
Control: Written information
Clinical report
forms
1 and 7 years Low Primary: Patient
knowledge about
foot care
Secondary: ulcer
incidence
Amputation rate
Plank, Austria,
200323
RCT 91 patients with diabetes
randomised
Intervention: 47
Control: 44
Intervention: Chiropodist visit at
least once a month
Control: chiropodist treatment
not specifically recommended
Clinical report
forms
386 days (368–
424, 25th–75th
percentile)
High (healed foot
ulcers)
Primary:
Recurrence rate
of ulcers
Secondary:
Amputation rate
Death
Sowell, USA,
199924
Cohort 255 256 with diabetes or
PVD or gangrene followed
over time
Intervention: Podiatric Medical
care—receipt of any M0101
services
Comparison: Did not receive
podiatry (M0101) services
Medicare
claims
database
1 year Unknown Number of
amputations
Lipscombe,
Canada,
200337
Cohort 132 patients with diabetes
on peritoneal dialysis (PD)
Intervention: Assessment,
education and footcare by
chiropody
Medical charts 3 years High Number of
amputations
Lavery, USA,
201021
Cohort 300 high-risk patients with
diabetes
150 with an ulcer history
150 on dialysis followed
over time
Intervention: Podiatry services
—number of visits to podiatrist
for prevention, ulcer treatment
of other pathology
Claims data
and electronic
medical records
30 months High (history of foot
ulcer)
Amputation rate
Ulcer incidence
Sloan, UK,
201038
Cohort 189 598 patients with
diabetes followed over time
Participants grouped into
different stages (1–4) of
disease depending on
severity of symptoms and
signs
Intervention: Care provided by
podiatrist
Comparison: Care provided by
‘other health professional’—GP/
internist/endocrinologist/nurse/
physician assistant
Medicare
claims
database
6 years Stage 1: Moderate
Stage 2: High
Stage 3: Active
Stage 4: Active
Amputation rate
RCT, randomised controlled trial.
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Table 3 Quality assessment of included cohort studies
Study (author,
country, year)
Type of
study Base population Confounding Losses to follow-up Analysis
Sowell, USA,
199924
Cohort All Medicare population at risk for
lower extremity amputation in
1993–1994
Not addressed—only looked
at 1 variable—
acknowledged as a
limitation
No losses to follow-up Amputation incidence rates with
and without exposure to podiatry
Lipscombe,
Canada, 200337
Cohort Patients in Peritoneal Dialysis
program at University Health
Network, between January 1997
and December 1999
Data on confounding
variables collected
No losses to follow-up Descriptive stats
Lavery, USA,
201021
Cohort Patients with diabetes attending
Scott and White Health Plan,
Texas, USA
Data on confounding
variables collected
150 consecutive patients with at least
30 months follow-up from the time of
diagnosis recruited so no losses to
follow-up
Descriptive stats
Sloan, UK,
201038
Cohort All individuals with a DM-related
LEC diagnosis between 1994 and
2001
Data on confounding
variables collected
No losses to follow-up HRs adjusted for Medicare
expenditures from care received
from non-study health
professionals
Table 2 Quality assessment of included RCTs
Study
(author,
country,
year) Type of study Base population Randomisation Blinding Confounding
Losses to
follow-up Analysis
Ronnemaa,
Finland,
199722
RCT Community-based care in
Finland, receiving
antidiabetic drug treatment
from the national drug
reimbursement register
Randomisation
performed separately for
men/women and patients
</> 20 years. Method of
randomisation not
described
Outcome assessor
blinded to baseline
characteristics but no
further information on
blinding provided
Baseline
characteristics
not described
Follow-up
completed by 63%
of patients in
intervention group
and 62% patients in
control group at
7 years
No intention
to treat
analysis
undertaken
Plank,
Austria,
200323
RCT All in routine outpatient
care at hospital diabetic
foot clinic in Austria
Subjects were assigned
a patient number in
ascending order and
randomly allocated to the
intervention or control
group
Allocation
concealment ensured
Similar baseline
characteristics
All patients followed
up
Intention
to treat and
per protocol
analysis
RCT, randomised controlled trial.
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sensitivity analyses were planned for different levels of
baseline risk but there were insufﬁcient data.
Sources of potential bias should be considered in rela-
tion to the observational studies. Although information
was collected on potential confounders in many of the
included observational studies, the analyses were not
adjusted for potential confounders and sources of bias.
Clinical practices may vary per individual and per loca-
tion. Guidelines have been recently developed to stand-
ardise referral of patients with diabetes to podiatry.14
Healthcare-seeking behaviours are complex and multi-
factorial and ethnicity and socioeconomic position can
inﬂuence attendance at podiatry.26 27 Level of disease
may also inﬂuence a patient’s decision to attend the
podiatrist and create a self-selection bias in the patients
with diabetes who visit the podiatrist. Patients who
received healthcare services in early stages of disease
may be more likely to engage in other healthy lifestyle
behaviours, for example, healthy diet, not smoking and
this phenomenon of ‘healthy user bias’ has been previ-
ously documented.28 In their retrospective cohort study,
Sowell et al24 reported 20 LEAs in the intervention
group and 130 in the control group (noting that the
population at risk in this study is patients with diabetes
and/or gangrene and/or PVD). This study described
the majority of included participants with the outcome
of LEA. However, their analysis did not adjust for import-
ant potential confounders which limit the conclusions
that can be drawn from this study.
The issues of bias and confounding are minimised by
the gold standard technique of randomisation in RCTs.
However, there is a lack of RCTs in this area. The two
Table 4 Results of included studies
Study (author,
country, year) Type of study Primary outcome
Baseline risk as
per diabetic foot
risk stratification14
Relative risk of amputation
with contact with a
podiatrist compared with no
contact with a podiatrist
Ronnemaa, Finland,
199722 16
RCT Diabetes-related
amputation:
One year follow-up:
Intervention: 0 Control: 0
7-years follow-up:
Intervention: 1 Control: 0
Low 2.96
Plank, Austria, 200323 RCT Diabetes-related
amputation:
1-year follow-up:
Intervention: 2 Control: 1
High (healed foot
ulcers)
0.92
Sowell, USA, 199924 Cohort Amputation related to
diabetes/gangrene/PVD
1-year follow-up:
Intervention: 20
Control: 130
Unknown 0.25
Lipscombe, Canada,
200337
Cohort Diabetes-related
amputation:
Amputation during any of
the 3 years of the study:
Intervention: 11 Control: 4
High 2.16
Lavery, USA, 201021 Cohort Diabetes-related
amputation:
Actual number of
amputations not outlined
Amputation incidence
density:
58.7 in Dialysis Group
per 1 000 person-years
13.1 in Ulcer Group per
1 000 person-years
High (history of foot
ulcer)
Unknown
Sloan, UK, 201038 Cohort Diabetes-related
amputation:
6-year follow-up: actual
number of amputations
not outlined
Stage 1: Moderate
Stage 2: High
Stage 3: Active
Stage 4: Active
Stage 1 disease : 2.20
Stage 2 disease : 0.85
Stage 3 disease : 0.44
Stage 4 disease : 0.36
RCT, randomised controlled trial.
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available RCTs have a lack of power as few participants
had the outcome of LEA. The most likely cause of the
low numbers of outcomes in the included studies is
length of follow-up. LEA takes years to develop,
especially from the time-point when a patient is classi-
ﬁed as low risk. In the ﬁrst included RCT, Plank et al23
described two LEAs in the intervention group and one
in the control group. In the second RCT, Ronnemaa
et al22 noted no LEA after 1 year of follow-up and one
LEA in the intervention group after 7 years of
follow-up.16 Neither RCT was designed to assess LEA as
a primary outcome and thus, had insufﬁcient power to
detect a signiﬁcant difference for the outcome of LEA.
CONCLUSIONS AND IMPLICATIONS
Two Cochrane reviews have looked at the outcome of
LEA in patients with diabetes.16 17 These reviews con-
cluded that there is insufﬁcient evidence that brief edu-
cational interventions or complex interventions reduce
the risk of LEA. This systematic review concludes that
there is insufﬁcient evidence that contact with a podia-
trist reduces the risk of LEA in patients with diabetes.
Thus, this review cannot make any recommendations
about practice. To detect the true effect, adequately
powered RCTs and longer follow-up studies are needed
to examine the effect of contact with a podiatrist on
Figure 2 Forest plots of
meta-analysis of randomised
controlled trials (top) and cohort
studies (bottom) with the
intervention of contact with a
podiatrist on left side of plot.
Figure 3 Funnel plot of included studies (randomised
controlled trials and cohort studies).
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LEA in patients with diabetes. Perhaps, podiatry pro-
grammes could be rolled out in a manner designed to
answer the question of effect on outcomes such as LEA.
Such studies could also assess the impact of the timing
and intensity of the podiatry intervention on outcomes.
Perhaps studies focusing on high-risk participants are
too close in timing to the LEA event and studies of
lower-risk participants would be better to detect an
effect in LEA prevention.
International standards recommend a multidisciplin-
ary team should manage the footcare of a patient with
diabetes.14 Many studies have looked at the effects of a
multidisciplinary team of which podiatry serves as a
member of the team and found positive effects on
various outcomes.29–36 This may be a more realistic
reﬂection of how patients with diabetes are managed;
looking at one service in isolation could be ﬂawed as ser-
vices are seldom delivered in isolation. According to the
SIGN guidelines a multidisciplinary foot team should
include a podiatrist, diabetes physician, orthotist, dia-
betes nurse specialist, vascular surgeon, orthopaedic
surgeon and radiologist.14 A systematic review of the lit-
erature looking at the effectiveness of multidisciplinary
teams which include contact with a podiatrist would be
useful.
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